Business Standard

India starts probe after Uzbekistan cough syrup deaths, Noida firm responds

According to the ministry, chemical ethylene glycol was found in a batch of syrup during laboratory tests

cough syrup, medicine, cold
Premium

File photo of cough syrup. Photo: Shutterstock

Press Trust of India
The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in connection with the death of 18 children in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian firm, official sources said on Thursday.
 
The health ministry of Uzbekistan has claimed that the 18 children had consumed cough syrup, 'Doc-1 Max', manufactured by Noida-based Marion Biotech.
 
Hasan Harris, legal representative of Marion Biotech, said the governments of both countries are looking into the matter and inquiring.
 
"There is no problem from our end and no issue in testing. We have been there for the past ten years.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 29 2022 | 12:44 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com